The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1963, 90: 412-415.
Copyright © 1963 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nelson, E. L.
Right arrow Articles by Buras, N. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nelson, E. L.
Right arrow Articles by Buras, N. S.

Recognition of Foreign Erythrocytes by the Liver in Mice1

Eric L. Nelson2 and Netty S. Buras

From the Department of Bacteriology, University of California, Los Angeles, California

Abstract

1. An experimental model has been developed for the study of recognition by cells of the reticuloendothelial system (RES).
2. A quantitative method employing Cr51 labeled cells has been devised for studying phagocytosis of homologous and heterologous erythrocytes.
3. Homologous and heterologous red blood cells are phagocytized at different rates. The spleen primarily takes up homologous (mouse) red cells and the liver removes foreign (human, guinea pig, rabbit) erythrocytes.
4. Genetic differences among strains of mice may be reflected in their ability to take up in the spleen red cells of nonrelated donor mice.
5. The ratio of recovery of radioactivity (RR ratio) between the blood, spleen and liver may be used to characterize a system employing erythrocytes of a particular donor in any given recipient. A comparison of RR ratios obtained under varying experimental conditions may be expected to reflect responses in the recognition mechanism of the RES.

Footnotes

1 These studies were aided by contract Nonr-233(68) between the Office of Naval Research, Department of the Navy and the University of California, Los Angeles.

2 Present address: Allergan Pharmaceuticals, Santa Ana, California.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1963 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1963 by The American Association of Immunologists, Inc. All rights reserved.